BioLife Solutions
BLFS
180 hedge funds and large institutions have $1.21B invested in BioLife Solutions in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 35 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 59
7% more capital invested
Capital invested by funds: $1.13B → $1.21B (+$81.4M)
2.81% more ownership
Funds ownership: 98.09% → 100.89% (+2.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less funds holding
Funds holding: 195 → 180 (-15)
34% less call options, than puts
Call options by funds: $122K | Put options by funds: $184K
37% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$19M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.7M |
| 3 |
Millennium Management
New York
|
+$9.38M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.91M |
| 5 |
Rockefeller Capital Management
New York
|
+$5.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$7.23M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$5.95M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$5.02M |
| 4 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$4.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$4.46M |
BLFS Hedge Fund Activity: Q4 2024 in Review
180 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q4 2024, worth a combined $1.21B — up 7.2% from $1.13B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of BLFS and 22 opened new positions — a net loss of 13 holders — while 59 trimmed existing stakes and 67 added.
The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $19M. The largest seller was Portolan Capital Management, cutting an estimated $7.23M.
- 180 institutional investors held BioLife Solutions (BLFS) as of Q4 2024, down from 195 in Q3 2024.
- Funds reported $1.21B of BioLife Solutions stock for Q4 2024, up 7.2% quarter-over-quarter.
- 22 funds opened new BioLife Solutions positions in Q4 2024 and 35 closed out, a net change of -13 holders.
- The largest BioLife Solutions buyer in Q4 2024 was Massachusetts Financial Services, an estimated $19M added.
- The largest BioLife Solutions seller in Q4 2024 was Portolan Capital Management, an estimated $7.23M sold.
Based on aggregated 13F filings for Q4 2024.